Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-13

Clinical Trial Update: A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase II trial of chemo-radiotherapy plus INO-3112 for locally advanced cervical cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INO-3112 (DNA plasmid encoding interleukin-12 and HPV DNA plasmids)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: WITHDRAWN